Prestige And Pharmapark Add Bevacizumab To Russia Collaboration

Commercialization Agreement Signed In 2019 Over Herceptin Biosimilar

 
• By Dean Rudge
  
Meeting
The Singapore-based biotech’s HD204 bevacizumab biosimilar is currently undergoing a Phase III clinical study • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products